Months after causing safety concerns that led the FDA to hit a related trial with a clinical hold, a phase 2 trial of ...

AbbVie is looking south to boost its community-based clinical trials. | AbbVie is looking south to boost its community-based clinical trials. The Chicago-area pharma giant is partnering with Nashville ...

Teos Therapeutics is throwing in the towel. | iTeos Therapeutics is throwing in the towel. Two weeks after axing its ...

Merck KGaA has shown off data that fueled its $85 million bet on a late-phase treatment for a rare, locally aggressive tumor.

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

An international group of gene editing leaders has put out a call for a 10-year ban on heritable human genome editing (HHGE), ...